Courses

Differentiating S1P-Based Therapeutics for the Treatment of Patients with Multiple Sclerosis
Neurology

Differentiating S1P-Based Therapeutics for the Treatment of Patients with Multiple Sclerosis

This CME program will highlight recent advances in S1P-based therapeutics for the treatment of patients with multiple sclerosis. The expert faculty, Dr. Clyde Markowitz, will first review the pharmacologic characteristics of all S1P-based therapies to aid in clinical decision making for the early intervention of patients diagnosed with multiple sclerosis (MS). Following, he will discuss long term efficacy and safety ...
View Course

VTE and Anticoagulation - Guideline Updates for 2024
Cardiology

VTE and Anticoagulation – Guideline Updates for 2024

This 0.5-hour, Whiteboard Animation Webcast is designed to review the important current guidelines for VTE and anticoagulation. Primary care physicians, internists, family medicine physicians, allied healthcare professionals and other healthcare providers involved in the care of patients with VTE
  1. Discuss current guidelines for the anticoagulation management of VTE
I. Current Guidelines for the Anticoagulation Management of VTE Geoffrey ...
View Course
Review of New and Emerging Therapies that Improve Tolerability and Adherence in Patients with Relapsing Multiple Sclerosis
Neurology

Review of New and Emerging Therapies that Improve Tolerability and Adherence in Patients with Relapsing Multiple Sclerosis

This CME program is derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2024 Course. The expert faculty, Dr. Aaron Miller, will start by analyzing the unmet needs for patients with relapsing multiple sclerosis (RMS) including tolerance and adherence to long-term treatment. Following, he will review the clinical trial data for new and emerging injectable therapies, including glatiramer ...
View Course

Brain Penetrant BTK Update: Reducing Neuroinflammation to Optimize Outcomes for Patients with Multiple Sclerosis
Neurology

Brain Penetrant BTK Update: Reducing Neuroinflammation to Optimize Outcomes for Patients with Multiple Sclerosis

This CME program is derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2024 Course. The expert faculty, Dr. Fred Lublin, will first analyze current clinical trial data for BTK therapeutics to manage patients with multiple sclerosis. Following, he will review strategies for patient education, shared decision making, and overcoming barriers to treatment adherence. To conclude, Dr. Lublin ...
View Course

Clinical Update on Anti-CD20 Therapeutics for Patients with Relapsing Multiple Sclerosis
Neurology

Clinical Update on Anti-CD20 Therapeutics for Patients with Relapsing Multiple Sclerosis

This CME program is derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2024 Course. The expert faculty, led by Dr. Mark Freedman, will first cover the topic of b-cells and anti-CD20 as therapeutic targets in the multiple sclerosis (MS) treatment landscape. Following, recent clinical trial data of anti-CD20 monoclonal antibody therapeutics to treat patients with relapsing multiple ...
View Course
Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis
Neurology

Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis

This CME program will highlight updates in the multiple sclerosis treatment landscape, including anti-CD20 therapeutics. The expert faculty, Dr. Grace Gombolay, will first utilize a case-based format to review current guidelines as well as the typical clinical course in multiple sclerosis. Following, recent clinical trial data of both B-cell depleting and anti-CD20 therapeutics will be analyzed, along with the implications ...
View Course
The New Era of Biosimilar Therapeutics for Multiple Sclerosis
Neurology

The New Era of Biosimilar Therapeutics for Multiple Sclerosis

This CME program is derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2024 Course. The expert faculty, led by Dr. Jiwon Oh, will first provide an overview of biosimilar development, including an explanation of the steps for a proposed biosimilar antibody. Following, recent clinical trial data in the biosimilar treatment landscape will be reviewed, including drugs in ...
View Course
Shared Decision-Making and Patient Education to Promote Adherence to DOACs and Continuity of Care in VTE
Cardiology

Shared Decision-Making and Patient Education to Promote Adherence to DOACs and Continuity of Care in VTE

This 0.5-hour, Whiteboard Animation Webcast is designed to review collaboration with the multidisciplinary healthcare team and the patient to improve shared decision-making and promote adherence to DOACs for patients with VTE. Primary care physicians, internists, family medicine physicians, allied healthcare professionals and other healthcare providers involved in the care of patients with VTE
  1. Understand the role of patient education ...
    View Course
CAR T Research and Treatment Advances in Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL) and Follicular Cell Lymphoma (FL) Therapies
Oncology

CAR T Research and Treatment Advances in Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL) and Follicular Cell Lymphoma (FL) Therapies

This CME program will highlight recent advances in the treatment and management of patients with chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and follicular cell lymphoma (FL). The expert faculty, led by Jeremy S. Abramson, MD, will first provide an update on CAR T cell therapies in 2024, including a summary of current approvals in the lymphoma treatment landscape ...
View Course
Strategies to Coordinate the Multidisciplinary Team for Secondary Prevention, Long-Term Treatment, and the Assessment of Bleeding Risk
Cardiology

Strategies to Coordinate the Multidisciplinary Team for Secondary Prevention, Long-Term Treatment, and the Assessment of Bleeding Risk

This 0.5-hour, Whiteboard Animation Webcast is designed to review collaboration with the multidisciplinary healthcare team for secondary prevention, long term treatment and bleeding risk assessment for patients with VTE. Primary care physicians, internists, family medicine physicians, allied healthcare professionals and other healthcare providers involved in the care of patients with VTE
  1. Develop strategies for collaboration with the multidisciplinary healthcare ...
    View Course